Latest Articles

Publication Date
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - Cure Today

CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models Cure Today

Published: March 17, 2026, 5:11 p.m.
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - CUREtoday.com

CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models CUREtoday.com

Published: March 17, 2026, 4:12 p.m.
CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors - Technology Networks

CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors Technology Networks

Published: March 17, 2026, 4:04 p.m.
UCLA Researchers Say Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer - Sierra Sun Times

UCLA Researchers Say Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer Sierra Sun Times

Published: March 17, 2026, 2:29 p.m.
New CAR-NKT cell therapy shows promise against aggressive endometrial cancer - News-Medical

New CAR-NKT cell therapy shows promise against aggressive endometrial cancer News-Medical

Published: March 17, 2026, 1:30 a.m.
Effectiveness of BMMSC and Dienogest on IL-1β, IL-8 Expression and Lesion Area in Endometriosis Mice.

Endometriosis is a chronic estrogen-dependent inflammatory disease that impairs fertility and quality of life. Dienogest, the current standard therapy, provides symptom relief but does not correct immune imbalance or prevent …

Published: March 17, 2026, midnight
Autophagy and Lysosomal Dysregulation in Endometriosis: Therapeutic Opportunities and Molecular Insights.

Published: March 17, 2026, midnight
Efficacy of probiotic supplementation in reducing primary dysmenorrhea: a double-blinded randomized controlled trial.

Primary dysmenorrhea is painful menstruation in the absence of pelvic pathology, whereas secondary dysmenorrhea is menstrual pain attributable to an underlying pelvic disease (e.g., endometriosis). Nonsteroidal anti-inflammatory drugs (NSAIDs) are …

Published: March 17, 2026, midnight
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests - Medical Xpress

Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests Medical Xpress

Published: March 16, 2026, 10:20 p.m.
Universal, Off-the-Shelf Immunotherapy Targets and Eliminates Endometrial Cancer - Bioengineer.org

Universal, Off-the-Shelf Immunotherapy Targets and Eliminates Endometrial Cancer Bioengineer.org

Published: March 16, 2026, 9:20 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!